ClinicalTrialsFinder

Local Therapy Clinical Trials in Beijing, None Selected

1 recruitingBeijing, None Selected, China

Showing 1–1 of 1 trials

Recruiting
Not Applicable

The Comparison of TACE-Lenvatinib With TACE-Lenvatinib-ablation for Intermediate Recurrent Hepatocellular Carcinoma

AblationSystemic TherapyRecurrent Hepatocellular Carcinoma+2 more
Sun Yat-sen University116 enrolled1 locationNCT06609850